Its (bi-allelic) mutation and/or deletion is considered the main molecular event in FH-deficient RCC, formerly classified as hereditary leiomyomatosis and renal cell carcinoma RCC (HLRCC-RCC). The gene discussed is FH; the disease is renal cell carcinoma.